新興產前遺傳檢測之臨床運用及倫理考量

Innovative Prenatal Testing: Clinical Applications and Ethical Considerations

黃美智(Mei-Chih Huang) ； 林秀娟(Shio-Jean Lin) ； 陳祉伶(Chih-Ling Chen) ； 黃子容(Tzu-Jung Huang)

《護理雜誌》 64卷5期 (2017/10) Pp. 5-10

https://doi.org/10.6224/JN.000062

摘要

藉由生物醫學科技之快速發展，新增許多產前遺傳檢測項目以積極協助孕婦增加對於其懷孕胎兒的了解。而市面亦常見各類針對孕婦產前檢驗的廣告。其中非侵入性胎兒染色體檢測提出可早期、安全又準確的檢測胎兒染色體異常疾病，此新興產前遺傳檢測究竟是指哪個項目？其適用性有何特殊考量？有哪些倫理考量或政策議題是需要去關注的？本文提供新興產前遺傳檢測之相關資訊、臨床指引及其倫理與政策議題，並以案例分析呈現不同情境之執行要點，期能有助於提升對於新時代遺傳檢測於孕產婦照護之多元資訊，以利提升產科照護之品質。

關鍵字

新興產前遺傳檢測 ； 非侵入性胎兒染色體檢測 ； 游離胎兒DNA染色體異常母血篩檢 ； 倫理考量

並列摘要

The biomedical technology related to prenatal screen/diagnosis has developed rapidly in recent decades. Many prenatal genetic examinations are now available to assist pregnant women to better understand the status and development of their fetus. Moreover, many commercial advertisements for innovative prenatal examinations are now shown in the media. Cell-free DNA Screening (cfDNA screening), a non-invasive prenatal testing (NIPT) procedure, is a safe and high accuracy test that may be done at an earlier gestational age to screen for fetal aneuploidy. The following questions should be considered when applying cfDNA screening in clinical practice: 1. what is cfDNA screening, 2. who are its potential users, and 3. what ethical and policy considerations are associated with this examination? This article provides relevant information, clinical practice guidelines, and ethical/ policy considerations related to cfDNA screening. Discussing cases involving different clinical situations helps promote understanding of cfDNA screening and maternal-care quality.

並列關鍵字

innovative prenatal testing ； non-invasive prenatal testing ； cell-free DNA screening for fetal aneuploidy ； ethical consideration

參考文獻

呂宜珍、林秀娟、黃美智（2003）．新生兒篩檢之社會衝擊與倫理考量．台灣醫學，7（5），774–779。[Lu, I. C., Lin, S. J., & Huang, M. C. (2003). Social impact and ethical considerations of newborn screening. Formosan Journal of Medicine, 7(5), 774–779.] doi:10.6320/FJM.2003.7(5).14

de Jong, A., & de Wert, G. M. W. R. (2015). Prenatal screening: An ethical agenda for the near future. Bioethics, 29(1), 46-55. doi:10.1111/bioe.12122

Deans, Z., Clarke, A. J., & Newson, A. J. (2015). For your interest? The ethical acceptability of using non-invasive prenatal testing to test ‘purely for information'. Bioethics, 29(1), 19-25. doi:10.1111/bioe.12125

Dondorp, W., de Wert, G., Bombard, Y., Bianchi, D. W., Bergmann, C., Borry, P., ... American Society of Human Genetics. (2015). Non-invasive prenatal testing for aneuploidy and beyond: Challenges of responsible innovation in prenatal screening. European Journal of Human Genetics, 23(11), 1438-1450. doi:10.1038/ejhg.2015.57

Samura, O., Sekizawa, A., Suzumori, N., Sasaki, A., Wada, S., Hamanoue, H., ... Sago, H. (2017). Current status of non-invasive prenatal testing in Japan. The Journal of Obstetrics and Gynaecology Research, 43(8), 1245-1255. doi:10.1111/jog.13373